Schwarz Pharma AG - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Schwarz Pharma AG. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Schwarz Pharma AG. The Group's principal activity is to research, develop, manufacture and market pharmaceuticals. It involves in bulk manufacturing, packaging and material management of pharmaceutical drugs. It specializes in manufacturing solid oral dosage forms and packing with modern blister machines. It also provides raw material and packaging materials for pharmaceutical industries. The drugs are manufactured for the following concerns: Cardiovascular diseases, Gastro intestinal diseases, Urology and Central nervous system related diseases. It operates under the brand names Atmadisc, Deponit, Dycanil, Elantan, Firin, Harzol, Isoket, Naramig, Nipruss and Sita. The Group operates in Germany, Italy, the United Kingdom, the United States, Switzerland, China, Hong Kong and Philippines.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report